Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
PDF) Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
Plasma levels of tested cytokines and CA 15-3 in patients with breast... | Download Table
The CA 15-3 test and breast cancer: What it is and results
Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning | Nature Communications
Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram
M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1β | Scientific Reports
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Concentrations of CA 15-3, CEA and HER2 in patients with distant... | Download Scientific Diagram
Relationship between tumor markers CEA and CA 15-3 and recurrence breast cancer | Semantic Scholar
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
CEA and CA 15.3 serum concentrations in patients with primary... | Download Table
Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - ScienceDirect
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
